System Maintenance Notice

Please note that maintenance work is scheduled between 4 AM and 5 AM - CET. During this time, you may experience reduced performance. Thanks for your patience.

Yoshihiro J Akashi is an expert in Cardiology at St. Marianna Medical University Hospital (Japan). As of October 2026, ScienceLeadR ranks Yoshihiro J Akashi in the top 1% of experts worldwide for Ventricular Dysfunction and Cardiomyopathies, and in the top 1% of experts in Japan for Ventricular Outflow Obstruction. Yoshihiro J Akashi has authored 487 publications, the most recent in 2026, and is an investigator in 4 clinical trials, 1 of them ongoing. SLR score: 1,745 (community average: 125). How the SLR is computed.

LeadR Profile

Yoshihiro J Akashi St. Marianna Medical University Hospital Japan
1 745 ScienceLeadR Reputation 1745

Unlock

Register Login
Network Map

Cardiology

Subspecialties: Public Health - Medical Imaging - Biostatistics

Full career – Last 3 years

Main Topics

Publications and Clinical Studies

Publications – Clinical Studies

Profile data updated on

Organizations

Career arc: 2000 - 2026
Source: PubMed

St. Marianna Medical University Hospital

Publications Synthesis

Sources: PubMed, OpenAlex

Number : 487

Citations

Citations: 12 474 1st author: 30 Last author: 237 Unique author: 6

Main journals

Int J Cardiol 28
Circ J 27
J Cardiol 25
Cardiovasc Interv Ther 18
Eur Heart J 17

Best Journals

Circulation 4
N Engl J Med 3
Eur Heart J 2

Breakdown by type

Click a legend label to hide or show it in the chart.

Latest Publications

5 most recent indexed articles

Source: Pubmed

Title Journal Year Citations
Clinical impact of admission estimated glomerular filtration rate categories in patients with acute myocardial infarction.
PMID 42870066 — glomerular filtration rate, myocardial infarction, cardiovascular system		Heart Vessels20260
Sacubitril/valsartan and cardiac injury/stress and systemic inflammatory biomarkers in acute heart failure: a prespecified secondary analysis of the PREMIER study.
PMID 42725483 — valsartan, heart failure, heart, stress, physiological, growth differentiation factor 15, biomarkers, angiotensins, therapeutics		Eur Heart J Cardiovasc Pharmacother20260
Phenotypes, periprocedural hemodynamic changes, and impact of pulmonary hypertension in patients undergoing mitral transcatheter edge-to-edge repair.
PMID 42717158 — hypertension, hypertension, pulmonary, capillaries, heart, phenotype, hemodynamics		Cardiovasc Interv Ther20260
Management and Outcomes of Cardiac Sarcoidosis: Insights From the Nationwide MYSTICS Registry.
PMID 42717875 — registries, hospitalization, sarcoidosis, heart failure, heart, arrhythmias, cardiac, prognosis		Circ Heart Fail20260
Heart and Brain: Anatomic and Physiologic Relationship.
PMID 42716650 — heart failure, heart, brain, nervous system		Heart Fail Clin20260

Clinical Studies 4

Sources: ClinicalTrials, EU CTIS

Synthesis

By phase:

Phase 3 2
Phase 4 2

By status:

Completed 2
Active not recruiting 1
Unknown 1

By type:

Interventional 4

By Monocentric/Multicentric:

monocentric 2
multicentric2to4 0
multicentric5to9 0
multicentricup10 2

Main Topics

Ongoing Clinical Trials

Ongoing trial started since 2021, where this expert is an investigator

Source: ClinicalTrials

Study Phase Status Start
ShorT and OPtimal Duration of Dual AntiPlatelet Therapy 3 Study
NCT04609111 — stents, hemorrhage, angioplasty, clopidogrel, acute coronary syndrome, aspirin, everolimus, therapeutics		Phase 4Active not recruiting2021

LeadR Networks

Main global connection map

Sources: PubMed, OpenAlex, ClinicalTrials, EU CTIS